Veterans' PAD study pulled before it began
NCT ID NCT05648630
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study was designed to see if a plant-based supplement called PB125 could help veterans with peripheral artery disease (PAD) get more benefit from exercise. The idea was that PB125 might reduce inflammation and oxidative stress, making it easier for patients to walk and exercise. However, the study was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PB125 (a plant-based supplement)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION (D007249) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Utah Dept of Vascular Surgery
Salt Lake City, Utah, 84132, United States
-
VA Salt Lake City Health Care System, Salt Lake City, UT
Salt Lake City, Utah, 84148-0001, United States